AssetMark Inc
PPH icon

AssetMark Inc’s VanEck Pharmaceutical ETF PPH Stock Holding History

AssetMark Inc’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Hold
15
– – ﹤0.01% 3023
2026
Q1 		$1.56K Hold
15
– – ﹤0.01% 2930
2025
Q4 		$1.55K Hold
15
– – ﹤0.01% 2831
2025
Q3 		$1.35K Sell
15
-1
-6% -$88 ﹤0.01% 2722
2025
Q2 		$1.41K Sell
16
-51
-76% -$4.42K ﹤0.01% 2531
2025
Q1 		$6.11K Sell
67
-932
-93% -$83.9K ﹤0.01% 1949
2024
Q4 		$86.2K Sell
999
-5,492
-85% -$497K ﹤0.01% 1284
2024
Q3 		$617K Buy
6,491
+354
+6% +$33.6K ﹤0.01% 864
2024
Q2 		$561K Buy
6,137
+46
+0.8% +$4.11K ﹤0.01% 857
2024
Q1 		$552K Buy
6,091
+606
+11% +$53.1K ﹤0.01% 817
2023
Q4 		$446K Buy
5,485
+2,841
+107% +$223K ﹤0.01% 807
2023
Q3 		$211K Buy
+2,644
New +$213K ﹤0.01% 865

Other funds holding PPH

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
RBC
Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
CWRP
Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AssetMark Inc's PPH Position: Q2 2026 in Review

AssetMark Inc held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 15 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

AssetMark Inc first reported a position in PPH in Q3 2023 and has held it in 12 quarters since. The position peaked at $617K in Q3 2024. 62 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • AssetMark Inc held 15 shares of VanEck Pharmaceutical ETF worth $1.64K as of Q2 2026.
  • AssetMark Inc left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3023 holding.
  • AssetMark Inc first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and has held it in 12 quarters since.
  • AssetMark Inc's VanEck Pharmaceutical ETF position peaked at $617K in Q3 2024.
  • 62 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.